Gilead Shares Gain After Launching Phase 3 Studies For Coronavirus Treatment – TheStreet

0
633
Gilead Shares Gain After Launching Phase 3 Studies For Coronavirus Treatment – TheStreet

Gilead Sciences said remdesivir will be tested on around 1,000 patients with both moderate and severe symptoms of the respiratory-focused coronavirus.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here